Elucida Oncology's Series A Round

Elucida Oncology raised a round of funding on August 22, 2017.

Elucida Oncology is focused on transforming outcomes for patients with primary solid tumor and metastatic cancer. The company is leveraging the novel Target or Clear capabilities of its ultra-small C-…

Articles about Elucida Oncology's Series A Round: